Interventions to Improve HIV Antiretroviral Therapy Adherence

NCT03618511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 914

Last updated 2021-09-24

No results posted yet for this study

Summary

This study will explore whether financial incentives, reminders, information about HIV/AIDS and its treatment and anti-stigma counseling help improve anti-retroviral therapy (ART) adherence among HIV infected individuals in a resource-limited environment. The interventions will be randomized in the study population in a cross-cutting design, with a control group, a financial incentive treatment group, a reminders treatment group, a treatment group that receives both the financial incentive and reminder interventions. In addition, there will be an information treatment group, a stigma-relieving treatment group and a group that receives both information and stigma-relieving interventions. The primary outcomes of interest for this study will be the adherence to ART, measured by attendance rates at clinic appointments and refill collection rates.

Conditions

  • Human Immunodeficiency Virus (HIV) Infection

Interventions

BEHAVIORAL

Financial Incentive

Financial Incentive: Participants will receive monthly financial incentives each time they refill the ART medication on time for six months

BEHAVIORAL

Reminders

Reminders: Participants will receive monthly reminder phone calls before their ART medication refill is due for six months.

BEHAVIORAL

Financial Incentive and Reminders

Interaction: Participants receive both the Financial Incentives and Reminder Calls.

BEHAVIORAL

Information

Information: show the participants a video about HIV progression, mechanism of ART, the benefit of adhering to ART.

BEHAVIORAL

Stigma-relieving

Stigma-Reliving: Upon recruitment, inform the participants of the results of a recent population survey regarding people's attitudes towards HIV, if they overestimate the social stigma related to HIV. This intervention intends to reduce the stigma-concern faced by the patients.

BEHAVIORAL

Information and Stigma-relieving

Information and Stigma-relieving: Upon recruitment, show the participants a video about HIV progression, mechanism of ART, the benefit of adhering to ART. In addition, inform the participants of the results of a recent population survey regarding people's attitudes towards HIV, if they overestimate the social stigma related to HIV. This intervention intends to reduce the stigma-concern faced by the patients.

Sponsors & Collaborators

Principal Investigators

  • James Riddell IV, MD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-06
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Mozambique

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03618511 on ClinicalTrials.gov